Rating Change
Barclays analysts reiterated a Overweight rating on Henry Schein, Inc. (NASDAQ:HSIC) on August 06, 2026.
reiterateNASDAQ:HSIC
Barclays Reiterates Overweight Rating on Henry Schein, Inc. (HSIC)
Rating Change Barclays analysts reiterated a Overweight rating on Henry Schein, Inc. (NASDAQ:HSIC) on August 06, 2026. Market Context Henry Schein, Inc.
Market Context
Henry Schein, Inc. operates in the Healthcare sector. The stock currently trades at $88.32 with a market capitalization of $9.3B. The stock has gained 25.9% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Henry Schein, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Henry Schein, Inc.
Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 06, 2026 | Barclays | Overweight | N/A |
| Aug 05, 2026 | Citigroup | Buy | N/A |
| Aug 05, 2026 | UBS | Neutral | N/A |
| Aug 05, 2026 | BTIG | Buy | N/A |
| Jul 29, 2026 | Piper Sandler | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View HSIC Stock Page
Frequently Asked Questions
What does a Overweight rating mean for HSIC?
A Overweight rating from Barclays reflects the analyst's outlook on Henry Schein, Inc. (NASDAQ:HSIC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HSIC forecast page.
